News
June has seen a slew of executive hires, promotions, exits and layoffs across the healthcare sector. For example, CVS Health ...
The Supreme Court upheld the constitutionality of an Affordable Care Act provision requiring insurance coverage of certain preventive services without cost-sharing. Many healthcare leaders applauded ...
Hinge Health and Omada Health. During a recent panel discussion, venture capitalists shared lessons learned about health tech ...
How Emerging Hospital Bed Technology Can Help Patients Rest Easier And Recover Faster - MedCity News
Despite their necessity, beds and surfaces do not always receive proportional attention and innovation — even as the risks associated with prolonged bed rest remain a key priority for caregivers.
Cigna's new digital tools include an AI-powered virtual assistant, personalized provider matching and cost tracking.
During AHIP 2025, AHIP executives discussed the impact the proposed budget bill could have on Medicaid and the individual market.
If the One Big Beautiful Bill Act is signed into law, it would result in a $50.4 billion reduction in federal Medicaid spending on rural hospitals over the next decade, which could put 338 rural ...
AstraZeneca Turns to CSPC Pharma Again, Putting Up $110M to Start Multi-Drug R&D Pact - MedCity News
AstraZeneca’s R&D collaboration with CSPC Pharmaceutical Group includes an oral small molecule for immunological diseases, which would offer a dosing edge over currently available injectable ...
The Trump administration has cancelled $766 million in contracts to develop mRNA vaccines against potential pandemic flu viruses. In addition, since President Donald Trump took office, at least ...
Workplace violence prevention is an ongoing and organic process. Federal and state regulations change frequently, so employers may consider regularly reviewing and updating their prevention plans ...
Pfizer drug Braftovi achieved statistically significant and clinically meaningful improvement in overall survival for colorectal cancer patients in a Phase 3 clinical trial. The results will be ...
In this episode of the MedCity Pivot Podcast, editor-in-chief Arundhati Parmar, speaks with Helix CEO James Lu about his company and how far precision medicine has come.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results